Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-β by high glucose, not by angiotensin II

Diabetes

Volumn 46, Issue 5, 1997, Pages 834-840

  Van Det, Nicole F ^a   Verhagen, Nicole A M ^a   Tamsma, Jouke T ^a   Berden, Jo H M ^b   Bruijn, Jan A ^a   Daha, Mohamed R ^a   Van Der Woude, Fokko J ^a,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; FIBRONECTIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FETUS; GLOMERULUS; HUMAN; HUMAN CELL; HYPERGLYCEMIA; KIDNEY EPITHELIUM; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RNA ANALYSIS;

EID: 0030949399     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.46.5.834     Document Type: Article

References (62)

1. Osterby R, Gundersen HJG, Horlyck A, Kroustrup JP, Nyberg G, Westberg G: Diabetic glomerulopathy, structural characteristics of the early and advanced stages. Diabetes 32:79-82, 1983
2. Olson JL: Diabetes mellitus. In Pathology of the Kidney. Heptinstall RH, Ed. London, Little, Brown, 1995, p. 1715-1763
3. Striker GE, Striker LJ: Biology of disease: glomerular cell culture. Lab Invest 53:122-131, 1985
4. van Det NF, Tamsma JT, van den Born J, Verhagen NAM, van den Heuvel LPWJ, Lowik CWGM, Berden JHM, Bruijn JA, Daha MR, van der Woude FJ: Differential effects of angiotensin II and transforming growth factor-β on the production of heparan sulfate proteoglycan by mesangial cells in vitro. J Am Soc Nephrol 7:1015-1023, 1996
5. Border WA, Okuda S, Languino LR, Ruoslahti E: Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int 37:689-695, 1990
6. Nakamura T, Miller D, Ruoslahti E, Border WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-1. Kidney Int 41:1213-1221, 1992
7. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor-β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
8. Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, Maki S: Transforming growth factor-β protein and mRNA in normal and diseased human kidneys. Lab Invest 68:154-163, 1993
9. Yamamoto T, Noble NA, Miller DE, Border WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927, 1994
10. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-1. Nature 346:371-374, 1990
11. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
12. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 93:536-542, 1994
13. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension. J Clin Invest 77:1993-2000, 1986
14. Fogo A, Yoshida Y, Glick AD, Homma T, Ichikawa I: Serial micropuncture analysis of glomerular function in two rat models of glomerulosclerosis. J Clin Invest 82:322-330, 1988
15. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 75:612-619, 1985
16. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1465-1462, 1993
17. Ray P, Agyuilera G, Kopp JB, Horikoshi S, Klotman PE: Angiotensin II receptor-mediated proliferation of cultured human mesangial cells. Kidney Int 40:764-771, 1991
18. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
19. Wolf G, Haberstroh U, Neilson EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140:95-107, 1992
20. Ray PE, Bruggeman LA, Horikoshi S, Aguilera G, Klotman PE: Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT 1 receptors. Kidney Int 45:177-184, 1994
21. Yamada H, Sexton P, Chai S, Adam W, Mendelsohn FAO: Angiotensin II receptors in the kidney: localization and physiological significance. Am J Hypertension 3:250-255, 1990
22. Bianchi C, Gutkowska J, Thibault G, Garcia R, Genest J, Cantin M: Distinct localization of atrial natriuretic factor and angiotensin II binding sites in the glomerulus. Am J Physiol 251:F594-F602, 1986
23. van Son JPHF, Mentzel S, Dijkman HBPM, de Jong AS, Bosch MJM, Wetzels JFM, Koene RAP, Assman KJM: Mouse podocytes in culture express aminopeptidase A (APA), but not other components of the renin angiotensin system (RAS) (Abstract). J Am Soc Nephrol 6:857, 1995
24. van der Woude FJ, Michael AF, Muller E, van der Hem GK, Vernier RL, Kim Y: Lymphohaemopoietic antigens of cultured human glomerular epithelial cells. Br J Exp Path 70:73-82, 1989
25. van Det NF, van den Born J, Tamsma JT, Verhagen NAM, van den Heuvel LPWJ, Berden JHM, Bruijn JA, Daha MR, van der Woude FJ: Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro. Biochem J 307:759-768, 1995
26. Müller GA, Müller G: Characterization of renal antigens on distinct parts of the human nephron by monoclonal antibodies. Klin Wochenschr 61:893-902, 1983
27. Lucas C, Bald LN, Fendly BM, Mora-Worms M, Figari IS, Patzer EJ, Palladino MA: The autocrine production of transforming growth factor-betal during lymphocyte activation: a study with monoclonal antibody based ELISA. J Immunol 145:1415-1422, 1995
28. Nahman NS, Leonhart KL, Cosio FG, Hebert CL: Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int 41:396-402, 1992
29. Lowik CWGM, Alblas MJ, van de Ruit M, Papapoulos SE, van der Pluim G: Quantification of adherent and nonadherent cells cultured in 96-well plates using the supravital stain neutral red. Anal Biochem 231:426-433, 1993
30. Bergsma DJ, Ellis C, Kumar C, Nuthulaganti P, Kersten H, Elshourbagy N, Griffin E, Stadel JM, Alyar N: Cloning and characterization of a human angiotensin II type 1 receptor. Biochem Biophys Res Com 183:989-995, 1992
31. Martin MM, Su B, Elton TS: Molecular cloning of the human angiotensin II type. Biochemical and biophysical research communications. Biochem Biophys Res Com 205:645-651, 1994
32. Ponte P, Ng SY, Engel J, Gunning P, Kedes L: Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of human beta-actin cDNA. Nucl Acids Res 12:1687-1696, 1984
33. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1983
34. Church GM, Gilbert W: Genomic sequencing. Proc Natl Acad Sci USA 81:1991-1995, 1984
35. Feinberg AP, Vogelstein B: A technique for radio labelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983
36. De Gasparo M, Levens NR: Pharmacology of angiotensin II receptors in the kidney. Kidney Int 46:1486-1491, 1994
37. Kakuchi J, Ichiki T, Kiyama S, Hogan BLM, Fogo A, Inagami T, Ichikawa I: Development expression of renal angiotensin II receptor genes in the mouse. Kidney Int 47:140-147, 1995
38. Shanmugam S, Lenkei ZG, Gasc JMR, Corvol PL, Llorens-Cortes CM: Ontogeny of angiotensin II type 2 (AT2) receptor mRNA in the rat. Kidney Int 47:1095-1100, 1995
39. Ciuffo GM, Heemskerk FMJ, Saavedra JM: Purification and characterization of angiotensin II ATR2 receptors from neonatal rat kidney. Proc Natl Acad Sci USA 90:11009-11013, 1993
40. Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 922:736-744, 1993
41. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
42. Mauer SM: Structural-functional correlations of diabetic nephropathy. Kidney Int 45:612-622, 1994
43. Osterby R: Glomerular structural changes in type I (insulin dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologia 35:803-812, 1992
44. Tamsma JT, van den Born J, Bruijn JA, Assmann KJM, Weening JJ, Berden JHM, Wieslander J, Schrama E, Hermans J, Veerkamp JH, Lemkes HHPJ, van der Woude FJ: Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37:313-320, 1994
45. Ayo SH, Radnik RA, Garoni JA, Glass II WF, Kreisberg JI: High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 136:1339-1348, 1990
46. Ayo SH, Radnik RA, Glass II WF, Garoni JA, Rampt ER, Appling DR, Kreisberg JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260:F185-F191, 1991
47. Danne TM, Spiro MJ, Spiro RG: Effect of high glucose on type IV collagen in cultured rat glomerular epithelial, endothelial, and mesangial cells. Diabetes 42:170-177, 1993
48. Haneda M, Kikkawa R, Horide N, Togawa M, Koya D, Kajiwara N, Ooshima A, Shigeta Y: Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells. Diabetologia 34:198-200, 1991
49. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP: High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol 28:F704-F714, 1990
50. Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN: Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule. Kidney Int 41:107-114, 1992
51. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 42:647-656, 1992
52. Calgliero E, Roth T, Taylor AW, Lorenzi M: The effects of high glucose on human endothelial cell growth and gene expression are not mediated by transforming growth factor-β. Lab Invest 73:667-673, 1995
53. Goldfarb S, Ziyadeh FN, Kern EFO, Simmons DA: Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats. Diabetes 40:465-471, 1991
54. Ziyadeh FN, Simmons DA, Snipes ER, Goldfarb S: Effect of myo-inositol on cell proliferation and collagen transcription and secretion in proximal tubule cells cultured in elevated glucose. J Am Soc Nephrol 1:1220-1229, 1991
55. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
56. Throckmorton DC, Brogden AP, Min B, Ramussen H, Kashgarian M: PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int 48:111-117, 1995
57. van Obberghen-Schilling E, Roche NS, Flanders KC, Sporn MB, Roberts AB: Transforming growth factor-β1 positively regulates its own expression in normal and transformed cells. J Biol Chem 263:7741-7746, 1988
58. Yamaguchi Y, Mann DM, Ruoslahti E: Negative regulation of transforming growth factor-beta (TGF-β) by the proteoglycan decorin. Nature 281-284, 1990
59. Craven PA, Studer RK, Negrete H, DeRubertis FR: Protein kinase C in diabetic nephropathy. J Diabetes Complications 9:241-245, 1995
60. Ziyadeh FN: Mediators of hyperglycemia and the pathogenesis of matrix accumulation in diabetic renal disease. Miner Electrolyte Metab 21:292-302, 1995
61. Kim SJ, Denhez F, Kim KY, Holt JH, Sporn MB, Roberts AB: Activation of the second promoter of the transforming growth factor-β1 gene by transforming growth factor-β1 and phorbol ester occurs through the same target sequences. J Biol Chem 264:19373-19378, 1989
62. Wenzel UO, Fouqueray B, Biswas P, Grandaliano G, Choudhury GG, Abboud HE: Activation of mesangial cells by the phosphatase inhibitor vanadate: potential implications for diabetic nephropathy. J Clin Invest 95:1244-1252, 1995